JUAN JOSÉ PICAZO DE LA GARZA-rekin lankidetzan egindako argitalpenak (56)

2022

  1. Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates

    Enfermedades infecciosas y microbiologia clinica (English ed.), Vol. 40, Núm. 4, pp. 172-178

2020

  1. Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates

    Enfermedades Infecciosas y Microbiologia Clinica

2017

  1. Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing enterobacteriaceae

    Journal of Medical Microbiology, Vol. 66, Núm. 2, pp. 169-174

  2. In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 2, pp. 191-196

  3. Plazomicin activity against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

2016

  1. Compendio de microbiología

    Elsevier

2015

  1. Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii?

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 10, pp. 5959-5966

  2. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates

    Microbial Drug Resistance

  3. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains

    International Journal of Antimicrobial Agents

2014

  1. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: High percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 5, pp. 460-464

2013

  1. Aumento significativo de la resistencia a fosfomicina en cepas de escherichia coli productoras de β-lactamasas de espectro extendido (BLEE) aisladas de urocultivos (2005-2009-2011)

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 43-46

  2. Rapid diagnosis of invasive pneumococcal disease in pediatric population

    Journal of Microbiological Methods, Vol. 93, Núm. 2, pp. 116-120

2012

  1. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 1, pp. 167-169

  2. Klebsiella pneumoniae: Development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient

    Clinical Microbiology and Infection, Vol. 18, Núm. 1, pp. 61-66

  3. Rapid identification of clinical isolates of Bacteroides species by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry

    Anaerobe, Vol. 18, Núm. 1, pp. 163-165

2011

  1. Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: A 2-year (2007-2009) laboratory-based surveillance in Madrid

    Vaccine, Vol. 29, Núm. 9, pp. 1770-1776

  2. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance

    Diagnostic Microbiology and Infectious Disease, Vol. 70, Núm. 3, pp. 373-379

  3. In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 30, Núm. 12, pp. 1621-1625

  4. Staphylococcus aureus resistente a meticilina: Sensibilidad a la daptomicina a lo largo de un periodo de 10 años (2001-2010)

    Revista Espanola de Quimioterapia, Vol. 24, Núm. 2, pp. 107-111

2010

  1. Actividad comparativa de la daptomicina frente a Staphylococcus aureus resistente a meticilina y frente a estafilococos coagulasa negativa

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 1, pp. 13-16